Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy.
Shima M, Suzuki N, Nishikii H, Amano K, Ogawa Y, Kobayashi R, Ozaki R, Yoneyama K, Mizuno N, Sakaida E, Saito M, Okamura T, Ito T, Hattori N, Higasa S, Seki Y, Nogami K. Shima M, et al. Among authors: amano k. Thromb Haemost. 2024 Sep 12. doi: 10.1055/a-2384-3585. Online ahead of print. Thromb Haemost. 2024. PMID: 39134043 Free article.
A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A.
Shima M, Amano K, Ogawa Y, Yoneyama K, Ozaki R, Kobayashi R, Sakaida E, Saito M, Okamura T, Ito T, Hattori N, Higasa S, Suzuki N, Seki Y, Nogami K. Shima M, et al. Among authors: amano k. J Thromb Haemost. 2023 Mar;21(3):534-545. doi: 10.1016/j.jtha.2022.10.004. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696195 Free article. Clinical Trial.
Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study.
Ogawa S, Yamashita T, Yamazaki T, Aizawa Y, Atarashi H, Inoue H, Ohe T, Ohtsu H, Okumura K, Katoh T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Tabuchi T, Nakaya H, Nakayama T, Hirai M, Fukatani M, Mitamura H; J-RHYTHM Investigators. Ogawa S, et al. Circ J. 2009 Feb;73(2):242-8. doi: 10.1253/circj.cj-08-0608. Epub 2008 Dec 8. Circ J. 2009. PMID: 19060419 Free article. Clinical Trial.
Optimal timing of recombinant herpes zoster virus vaccination for a JAK inhibitor treatment in rheumatoid arthritis: a multicentre, open-label, randomised comparative study (STOP-HZ study): study protocol.
Takanashi S, Ohmura K, Misaki K, Ihata A, Matsui T, Tohma S, Saegusa J, Sato S, Matsubara T, Yamaoka K, Amano K, Miyamoto T, Mori Y, Kaneko Y. Takanashi S, et al. Among authors: amano k. BMJ Open. 2024 Nov 17;14(11):e090668. doi: 10.1136/bmjopen-2024-090668. BMJ Open. 2024. PMID: 39551586 Free PMC article.
1,358 results